Ischemic heart disease
Conditions
Interventions
None listed
Sponsors
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with (A) stable coronary artery disease (B) unstable angina (C) acute myocardial infarction (Type 1 by 3rd universal definition) without indication of primary PCI, who has intermediate stenosis at proximal segment of each coronary vessels (segments #1, #2, #3, #5, #6, #7, #11, or #13) detected on coronary computed tomography angiography (CCTA) or invasive coronary angiography (CAG) and undergo coronary magnetic resonance for plaque evaluation by T1WI within 3 months before/after anatomical evaluation by CCTA, CAG evaluation or both.
Exclusion criteria
Exclusion criteria: Patients with MRI contraindication Patients with chronic kidney disease (stage 4 and 5) or with hemodialysis Patients with pacemaker, implantable cardiodefibrillatior Patients with heart rhythm irregularity (Atrial fibrillation etc) Patients with claustrophobia Patients judged as inappropriate by each researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite of major adverse event (cardiac death, myocardial infarction (3rd universal definition: type1), new ischemia driven coronary revascularization) | — |
Secondary
| Measure | Time frame |
|---|---|
| All-cause death Cardiac death Cardiovascular death Myocardial infarction/unstable angina New ischemia driven coronary revascularization Occurrence of periprocedural myocardial injury during percutaneous coronary intervention (PCI) (3rd Universal definition type 4). Slow flow phenomenon during PCI. | — |
Countries
Japan
Contacts
Public ContactYasuhide Yasuhide Asaumi
National Cerebral and Cardiovascular Center Department of Cardiovascular Medicine
Outcome results
None listed